+

WO2003031940A3 - Proteines structurales et associees au cytosquelette - Google Patents

Proteines structurales et associees au cytosquelette Download PDF

Info

Publication number
WO2003031940A3
WO2003031940A3 PCT/US2002/032851 US0232851W WO03031940A3 WO 2003031940 A3 WO2003031940 A3 WO 2003031940A3 US 0232851 W US0232851 W US 0232851W WO 03031940 A3 WO03031940 A3 WO 03031940A3
Authority
WO
WIPO (PCT)
Prior art keywords
cytoskeleton
scap
associated proteins
structural
polynucleotides
Prior art date
Application number
PCT/US2002/032851
Other languages
English (en)
Other versions
WO2003031940A2 (fr
Inventor
Shanya D Becha
Umesh Bhatia
Julie J Blake
Mark L Borowsky
John D Burrill
Hsin-Ru Chang
Narinder K Chawla
Vicki S Elliott
Brooke M Emerling
Ian J Forsythe
Original Assignee
Incyte Genomics Inc
Shanya D Becha
Umesh Bhatia
Julie J Blake
Mark L Borowsky
John D Burrill
Hsin-Ru Chang
Narinder K Chawla
Vicki S Elliott
Brooke M Emerling
Ian J Forsythe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Shanya D Becha, Umesh Bhatia, Julie J Blake, Mark L Borowsky, John D Burrill, Hsin-Ru Chang, Narinder K Chawla, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe filed Critical Incyte Genomics Inc
Priority to JP2003534873A priority Critical patent/JP2005520493A/ja
Priority to AU2002343516A priority patent/AU2002343516A1/en
Priority to CA002460625A priority patent/CA2460625A1/fr
Priority to EP02780462A priority patent/EP1451212A2/fr
Publication of WO2003031940A2 publication Critical patent/WO2003031940A2/fr
Publication of WO2003031940A3 publication Critical patent/WO2003031940A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Plusieurs formes de réalisation de la présente invention concernent des protéines structurales et associées au cytosquelette (SCAP) ainsi que des polynucléotides qui identifient et codent SCAP. Des formes de réalisation de l'invention concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes; d'autres formes de réalisation se rapportent à des méthodes de diagnostic, de traitement ou de prévention des troubles associés à l'expression aberrante de SCAP.
PCT/US2002/032851 2001-10-12 2002-10-10 Proteines structurales et associees au cytosquelette WO2003031940A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003534873A JP2005520493A (ja) 2001-10-12 2002-10-10 構造及び細胞骨格関連タンパク質
AU2002343516A AU2002343516A1 (en) 2001-10-12 2002-10-10 Structural and cytoskeleton-associated proteins
CA002460625A CA2460625A1 (fr) 2001-10-12 2002-10-10 Proteines structurales et associees au cytosquelette
EP02780462A EP1451212A2 (fr) 2001-10-12 2002-10-10 Proteines structurales et associees au cytosquelette

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US32893101P 2001-10-12 2001-10-12
US60/328,931 2001-10-12
US36068101P 2001-10-19 2001-10-19
US60/360,681 2001-10-19
US34389601P 2001-11-02 2001-11-02
US60/343,896 2001-11-02
US34630801P 2001-11-09 2001-11-09
US60/346,308 2001-11-09
US33238501P 2001-11-16 2001-11-16
US60/332,385 2001-11-16
US34077601P 2001-12-07 2001-12-07
US60/340,776 2001-12-07
US34770302P 2002-01-11 2002-01-11
US60/347,703 2002-01-11

Publications (2)

Publication Number Publication Date
WO2003031940A2 WO2003031940A2 (fr) 2003-04-17
WO2003031940A3 true WO2003031940A3 (fr) 2004-04-01

Family

ID=27569679

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/032851 WO2003031940A2 (fr) 2001-10-12 2002-10-10 Proteines structurales et associees au cytosquelette

Country Status (5)

Country Link
EP (1) EP1451212A2 (fr)
JP (1) JP2005520493A (fr)
AU (1) AU2002343516A1 (fr)
CA (1) CA2460625A1 (fr)
WO (1) WO2003031940A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404209D0 (en) * 2004-02-25 2004-03-31 Uws Ventures Ltd Materials and methods for treatment of allergic disease
JP4592352B2 (ja) * 2004-08-13 2010-12-01 国立大学法人 奈良先端科学技術大学院大学 神経成長円錐局在分子Ｓｈｏｏｔｉｎ１もしくはそのスプライシングバリアントを利用した神経軸索の形成・伸長と神経再生への応用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Item G5149 is a GLY-Gln Bioactive Peptide that is a Fragment of SEQ ID NO:1 corresponding to Amino Acids 236-237 and 686-687 of SEQ ID NO:1", SIGMA CHEMICAL COMPANY CATALOG OF BIOCHEMICALS ORGANIC COMPOUNDSFOR RESEARCH, XX, XX, no. Item. G5149, 1 January 1993 (1993-01-01), XX, pages 1089, XP002973728 *
DATABASE GENBANK [online] November 1999 (1999-11-01), XP002973710, Database accession no. AB033088 *

Also Published As

Publication number Publication date
JP2005520493A (ja) 2005-07-14
AU2002343516A1 (en) 2003-04-22
WO2003031940A2 (fr) 2003-04-17
CA2460625A1 (fr) 2003-04-17
EP1451212A2 (fr) 2004-09-01

Similar Documents

Publication Publication Date Title
WO2001098468A3 (fr) Proteases
WO2003052075A3 (fr) Enzymes
WO2002008396A3 (fr) Proteases
WO2001098354A3 (fr) Recepteurs
WO2003029437A3 (fr) Proteines secretees
WO2003042357A3 (fr) Enzymes
WO2003004615A3 (fr) Proteines secretees
WO2002038744A3 (fr) Protéases
WO2002026950A3 (fr) Transferases
WO2002101009A3 (fr) Proteines structurelles et associees au cytosquelette
WO2001071004A3 (fr) Proteases
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2001085942A3 (fr) Proteines associees au cytosquelette
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2002024895A3 (fr) Facteurs de transcription et protéines à doigt de zinc
WO2002053719A3 (fr) Proteines associees au cytosquelette
WO2002020736A3 (fr) Proteases
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2001046443A3 (fr) Proteases
WO2003063769A3 (fr) Proteines associees aux vesicules
WO2004003162A3 (fr) Enzymes
WO2003016506A3 (fr) Proteines secretees
WO2003025542A3 (fr) Proteines associees a la reponse immunitaire
WO2003072729A3 (fr) Enzymes
WO2002048362A3 (fr) Proteines associees a l'embryogenese

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2460625

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003534873

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002780462

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002780462

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 2002780462

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002780462

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载